Status:
COMPLETED
US-Guided Biopsy in the Diagnosis of Musculoskeletal Soft-Tissue Tumors
Lead Sponsor:
Istituto Ortopedico Rizzoli
Conditions:
Soft Tissue Neoplasm
Soft Tissue Sarcoma
Eligibility:
All Genders
Brief Summary
A retrospective evaluation of soft tissue tumors that have undergone core needle biopsy with US guidance (US-CNB)
Detailed Description
The present study is designed to be the first step in the creation of an interdisciplinary platform collecting data on patients and procedures to provide a predictive tool to help physicians in the ma...
Eligibility Criteria
Inclusion
- Patients undergone US-CNB for soft tissue lesions at the Rizzoli Orthopaedic Institute
Exclusion
- Patients whose histological diagnosis is not available
Key Trial Info
Start Date :
September 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 20 2020
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT03452644
Start Date
September 20 2018
End Date
September 20 2020
Last Update
May 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Rizzoli Orthopaedic Institute
Bologna, Bo, Italy, 40136